Recruiting

Congenital Disorders

Sponsor:

Icahn School of Medicine at Mount Sinai

Code:

NCT04199000

Conditions

Congenital Disorders of Glycosylation

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this research is to study the natural history of congenital disorders of glycosylation and its causes and treatments.

Conditions

Congenital Disorders of Glycosylation

Study ID

NCT04199000

Start date

Oct 8, 2019

Status verified date

Jul, 2026

Completion date

Jul 31, 2030

Anticipated

Primary completion date

Jul 31, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Individuals with a genetically, enzymatically, or molecularly confirmed diagnosis of CDG or NGLY1 deficiency

Exclusion Criteria:

  • None

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Indicators of Disease Severity and Progression - organ system involvement [ Time Frame: Length of study, up to 5 years ]
  • Indicators of Disease Severity and Progression - degree of cognitive disability [ Time Frame: Length of study, up to 5 years ]
  • Indicators of Disease Severity and Progression - case-fatality [ Time Frame: Length of study, up to 5 years ]

Central Contacts and Locations

Central contacts

Eva Morava-Kozicz, PhD, MD

(504) 444-9386eva.morava@mssm.edu

Locations

Rady Children's Hospital

Recruiting

San Diego, California, United States, 92123

Contacts

Jennifer Friedman, MD

jrfriedman@rchsd.org

Corrine Blucher

cblucher@rchsd.org

Principal Investigator:

Jennifer Friedman, MD

Children's Hospital of Colorado

Recruiting

Aurora, Colorado, United States, 80045

Contacts

Principal Investigator:

Austin Larson, MD

Mayo Clinic Florida

Recruiting

Jacksonville, Florida, United States, 32224

Contacts

Karthik Muthusamy, MD

Muthusamy.Karthik@mayo.edu

Principal Investigator:

Karthik Muthusamy, MD

Boston Children's Hospital

Recruiting

Boston, Massachusetts, United States, 02115

Contacts

Principal Investigator:

Gerard Berry, MD

University of Minnesota

Recruiting

Minneapolis, Minnesota, United States, 55454

Contacts

Kyriakie Sarafoglou, MD

612-624-5409saraf010@umn.edu

Natalie Pogorelc

pogor022@umn.edu

Principal Investigator:

Kyriakie Sarfoglou, MD

Mayo Clinic in Rochester

Recruiting

Rochester, Minnesota, United States, 55905

Contacts

Clinical Genomics Research

5072669140RSTCGRESEARCH@mayo.edu

Principal Investigator:

Queenie Tan, MD, PhD

Icahn School of Medicine at Mount Sinai

Recruiting

New York, New York, United States, 10029

Contacts

Principal Investigator:

Jaya Ganesh, MD

Children's Hospital of Philadelphia

Recruiting

Philadelphia, Pennsylvania, United States, 19146

Contacts

Principal Investigator:

Andrew Edmondson, MD

Children's Hospital of Pittsburgh

Recruiting

Pittsburgh, Pennsylvania, United States, 15224

Contacts

Evgenia Sklirou, MD, FACMG

412-692-5070SklirouE@chp.edu

Angela Leshinski, MBA, RD, LDN

412-692-5232angela.leshinski@chp.edu

Principal Investigator:

Gerard Vockley, MD, PhD

Baylor College of Medicine

Recruiting

Houston, Texas, United States, 77030

Contacts

Principal Investigator:

Fernando Scaglia, MD, FACMG

Seattle Children's Hospital

Recruiting

Seattle, Washington, United States, 98105

Contacts

Principal Investigator:

Christina Lam, MD

More Information

Sponsor

Icahn School of Medicine at Mount Sinai

Last update posted

Jul 21, 2026

Last verified

Jul, 2026

Keywords

  • CDG
  • CDDG
  • Congenital Disorders of Glycosylation
  • Congenital Disorders of Deglycosylation
  • ALG1
  • ALG3
  • ALG6
  • ALG12
  • ALG13
  • COG6
  • DPAGT1
  • DPM1
  • EDEM3
  • MAN1B1
  • MPDU1
  • MPI
  • NGLY1
  • PGAP3
  • PGM1
  • PIGA
  • PIGG
  • PIGN
  • PIGS
  • PIGT
  • PMM2
  • SLC35A2
  • SLC35C1
  • SLC39A8
  • SRD5A3
  • SSR4
  • FUT8
  • GALNT2
  • MAN2B2
  • VMA21

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai on 2026-07-21.